Evaluation of Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and its Association with Clinicopathological Variables in Patients with Pancreatic - Egyptian Knowledge Bank

338619

Evaluation of Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and its Association with Clinicopathological Variables in Patients with Pancreatic

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Evaluation of (PARP-1) Expression in Gastric Carcinoma by Immunohistochemistry and Quantitative Real-Time PCR and its Relation to HER2 Status

Article

Prognostic Value of SMAD4 Expression in Pancreatic Ductal Adenocarcinoma and its Correlation with Clinicopathological Parameters and HER2 Status

Article

Expression of Her-2/neu in endometrial carcinoma and its relation with clinicopathological variables

Article

EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value

Article

Clinico-Pathological Study of Prognostic Factors in HER-2 Positive Patients with Breast Cancer

Article

Immunohistochemical Expression of HER2/NEU and CD10 in Urothelial Carcinoma of Urinary Bladder

Article

Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) and HER-2 In Oral Squamous Cell Carcinoma

Article

EpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study

Article

Slug, CD44 and Her-2/neu Immunohistochemical Expression in Gastric Carcinoma

Article

Quantitative Analysis of C-erbB2 and P53 Protein Levels in Breast Tumor Tissues and Study of Their Associations with Tumor biological Characteristics and Prognosis